Spheryx, Inc.
New York, NY · Founded 2014 · CIK 0001630562 · Medtech
Holographic video microscopy instrument for detecting and characterizing protein aggregates and contaminants in pharmaceutical formulations
spheryx.solutions →- Grants
- $6.4M
- 8 awards
- Sector median: 1
- Raised
- $1.7M
- 5 Form D · Jan 2026
- 9 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 3 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Total Holographic Characterization of Colloids Through Holographic Video Microscopy | $179,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Instrument for Holographic Characterization of Protein Aggregates | $318,318 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Total Holographic Characterization of Colloids Through Holographic Video Microscopy | $1,284,006 | |
| Federal grant | Department of Health and Human Services · Phase II · Instrument for Holographic Characterization of Protein Aggregates | $769,706 | |
| Private capital raised | Form D · SEC | $1,000,034 | |
| Federal grant | Department of Health and Human Services · Phase II · Instrument for Holographic Characterization of Protein Aggregates | $730,294 | |
| Federal grant | Department of Health and Human Services · Phase II · Instrument for Holographic Characterization of Protein Aggregates - This SBIR Phase II program is developing an instrument that uses holographic video microscopy to meet quality needs for biologics. | $113,502 | |
| Private capital raised | Form D · SEC | $525,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Instrument for Holographic Characterization of Protein Aggregates | $2,000,003 | |
| Federal grant | Department of Health and Human Services · Phase II · Instrument for Holographic Characterization of Protein Aggregates | $996,838 | |
| Private capital raised | Form D · SEC | $675,000 | |
| Private capital raised | Form D · SEC | $500,400 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1024 | Fio Corp | — | $11M |
| 1025 | Windgap Medical, Inc. | — | $41M |
| 1026 | Greenwings Biomedical, Inc. | — | — |
| 1027 | Spheryx, Inc. | — | $1.7M |
| 1028 | Angiotech Pharmaceuticals | — | — |
| 1029 | FERRIC CONTRAST, INC. | — | — |
| 1030 | ALIENBYTE Scientific Software Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David GrierDirector
- Laura PhilipsDirector · Executive Officer
Patents
- Automated Holographic Video Microscopy Assaygranted
- Holographic Characterization Of Irregular Particlesgranted
- Holographic Video Microscopy Cell Viability Assayapplication
- Holographic Characterization Of Irregular Particlesgranted
- Holographic Characterization Using Hu Momentsapplication
- Holographic Video Microscopy Cell Viability Assayapplication
- Holographic Characterization Using Hu Momentsapplication
- Holographic Characterization Using Hu Momentsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.